Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 6, 2023; 11(4): 780-787
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.780
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.780
Table 4 Number of glaucoma medications used in patients undergoing selective laser trabeculoplasty
Number of medications | Baseline | 1 d | 1 wk | 1 mo | 3 mo | 6 mo | 12 mo | 36 mo |
OAG | 3.39 ± 0.69 | 3.31 ± 0.82 | 2.75 ± 0.5 | 2.06 ± 0.79 | 2.19 ± 0.71 | 2.39 ± 0.64 | 2.34 ± 0.64 | 2.5 ± 0.69 |
P1 value | 0.083 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
PGS | 2.97 ± 0.74 | 2.85 ± 0.67 | 2.51 ± 0.56 | 1.33 ± 1.28 | 1.44 ± 1.23 | 1.77 ± 0.99 | 1.79 ± 1.02 | 1.9 ± 0.82 |
P1 value | 0.025 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
P2 value | 0.015 | 0.005 | 0.048 | 0.004 | 0.003 | 0.006 | 0.008 | 0.007 |
- Citation: Zhu J, Guo J. Selective laser trabeculoplasty as adjunctive treatment for open-angle glaucoma vs following incisional glaucoma surgery in Chinese eyes. World J Clin Cases 2023; 11(4): 780-787
- URL: https://www.wjgnet.com/2307-8960/full/v11/i4/780.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i4.780